{"created":"2025-02-18T09:13:57.214752+00:00","id":2003451,"links":{},"metadata":{"_buckets":{"deposit":"15eb7fc4-1eb3-4f66-bd1e-1487ed540cf9"},"_deposit":{"created_by":41,"id":"2003451","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"2003451"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02003451","sets":["1730444908512:1730444912377"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Reduction of hepatitis B surface antigen in sequential versus add -on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study","subitem_title_language":"en"},{"subitem_title":"HBe抗原陰性 B型慢性肝炎に対するペグインターフェロン・核酸アナログのシーケンシャル療法・アドオン療法におけるHBs抗原の低下に関する検討","subitem_title_language":"ja"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"辰川, 裕美子","creatorNameLang":"ja"},{"creatorName":"Tatsukawa, Yumiko","creatorNameLang":"en"}],"familyNames":[{"familyName":"辰川","familyNameLang":"ja"},{"familyName":"Tatsukawa","familyNameLang":"en"}],"givenNames":[{"givenName":"裕美子","givenNameLang":"ja"},{"givenName":"Yumiko","givenNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might not be reflected in this document. A definitive version was published in Antiviral Therapy, Vol 23, Issue 8, 01 Jan 2018, © 2018 International Medical Press."}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187087799":{"attribute_name":"Dissertation Number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第7639号"}]},"item_1617187112279":{"attribute_name":"Degree Name","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"},{"subitem_degreename":"Doctor of Philosophy in Medical Science","subitem_degreename_language":"en"}]},"item_1617187136212":{"attribute_name":"Date Granted","attribute_value_mlt":[{"subitem_dategranted":"2018-08-30"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_be7fb7dd8ff6fe43","subitem_version_type":"NA"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"Antiviral Therapy 2018; 23:639-646"}]},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.3851/IMP3240","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k7639_1.pdf","filesize":[{"value":"111.3 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2003451/files/k7639_1.pdf"},"version_id":"8e44049f-9dbf-47ff-a221-da63f10b2e26"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k7639_2.pdf","filesize":[{"value":"240.8 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2003451/files/k7639_2.pdf"},"version_id":"eeb85ee2-4d20-4645-a64e-956ec54ebfeb"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k7639_3.pdf","filesize":[{"value":"2.1 MB"}],"mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://hiroshima.repo.nii.ac.jp/record/2003451/files/k7639_3.pdf"},"version_id":"42590193-d43e-4e66-9606-589482af5018"}]},"item_1617944105607":{"attribute_name":"Degree Grantor","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"広島大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"15401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]},{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"en","subitem_degreegrantor_name":"Hiroshima University"}]}]},"item_1732771732025":{"attribute_name":"旧ID","attribute_value":"46913"},"item_title":"Reduction of hepatitis B surface antigen in sequential versus add -on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study","item_type_id":"40003","owner":"41","path":["1730444912377"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-03-18"},"publish_date":"2023-03-18","publish_status":"0","recid":"2003451","relation_version_is_last":true,"title":["Reduction of hepatitis B surface antigen in sequential versus add -on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2025-02-20T01:56:14.350568+00:00"}